Skip to main content

Treatment Outcomes

Median survival for polycythemia vera (PV) patients is 10.9 years. People with PV may have a shorter-than-normal life span, but with careful medical supervision and therapy, PV can usually be managed effectively for a long time. In some cases, however, PV may progress to myelofibrosis, acute myeloid leukemia or myelodysplastic syndrome.

To download lists of suggested questions to ask your healthcare providers, click here.

 

 

Related Links